Home » Stocks » AIKI

AIkido Pharma, Inc. (AIKI)

Stock Price: $0.514 USD 0.000 (0.00%)
Updated November 27, 1:00 PM EST - Market closed
After-hours: $0.514 +0.000 (0.08%) Nov 27, 4:51 PM

Stock Price Chart

Key Info

Market Cap 17.95M
Revenue (ttm) 9,000
Net Income (ttm) -11.69M
Shares Out 34.92M
EPS (ttm) -0.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $0.514
Previous Close $0.514
Change ($) 0.000
Change (%) 0.00%
Day's Open 0.511
Day's Range 0.490 - 0.520
Day's Volume 566,568
52-Week Range 0.489 - 3.220

More Stats

Market Cap 17.95M
Enterprise Value n/a
Earnings Date (est) Jan 1, 1970
Ex-Dividend Date n/a
Shares Outstanding 34.92M
Float n/a
EPS (basic) -0.36
EPS (diluted) -0.36
FCF / Share -0.13
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.06M
Short Ratio 1.38
Short % of Float n/a
Beta 1.99
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 1,994.33
PB Ratio 0.61
Revenue 9,000
Operating Income -4.75M
Net Income -11.69M
Free Cash Flow -4.37M
Net Cash 27.30M
Net Cash / Share 0.78
Gross Margin 100.00%
Operating Margin -52,811.11%
Profit Margin -129,888.90%
FCF Margin -48,522.22%
ROA -26.67%
ROE -61.87%
ROIC -53.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$1,802*
Low
1,802
Current: $0.514
High
1,802
Target: 1,802
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue0.010.031.240.880.030.010.030.02-1.43
Revenue Growth-67.86%-97.73%40.94%2557.58%230%-62.96%35%---
Gross Profit0.010.031.240.880.030.010.020.02-0.91
Operating Income-5.69-6.87-3.82-8.55-52.01-30.61-15.35-3.47-4.19-8.01
Net Income-4.181.73-3.31-6.48-51.47-30.53-17.97-3.860.02-7.74
Shares Outstanding2.511.901.300.870.400.240.02---
Earnings Per Share-1.670.91-2.5528.73-106.17-125.00-1,101.48-1,137.01-415.08-6,912.53
Operating Cash Flow-3.02-2.73-3.270.07-4.62-9.52-5.27-3.82-4.36-8.69
Capital Expenditures--0.04--------
Free Cash Flow-3.02-2.77-3.270.07-4.62-9.52-5.27-3.82-4.36-8.69
Cash & Equivalents0.952.724.206.163.534.313.134.504.915.58
Net Cash / Debt0.952.724.206.163.534.313.134.504.915.58
Assets11.2813.258.9711.2813.6961.1669.854.765.667.02
Liabilities0.751.154.875.964.941.641.553.901.862.58
Book Value10.5312.104.115.328.7553.5948.300.853.804.44
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name AIkido Pharma, Inc.
Country United States
Employees 3
CEO Anthony C. Hayes

Stock Information

Ticker Symbol AIKI
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AIKI

Description

Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.